[1] |
FOROUZANFAR M H,, FOREMAN K J,, DELOSSANTOS A M, et al.Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis[J]. Lancet, 2011, 378(9801): 1461-1484.
doi: 10.1016/S0140-6736(11)61351-2
|
[2] |
SUNG H,, FERLAY J,, SIEGEL R L, et al.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.
doi: 10.3322/caac.21660
|
[3] |
孙可欣,, 郑荣寿,, 张思维, 等.2015年中国分地区恶性肿瘤发病和死亡分析[J]. 中国肿瘤, 2019, 28(1): 1-11.
|
|
SUN K X,, ZHENG R S,, ZHANG S W, et al.Report of cancer incidence and mortality in different areas of China, 2015[J]. China Cancer, 2019, 28(1): 1-11.
|
[4] |
国家癌症中心.中国肿瘤登记工作指导手册-2016[M]. 北京:人民卫生出版社, 2016: 59-75.
|
|
National Cancer Center.China cancer registration instruction manual-2016[M]. Beijing:People's Health Publishing House, 2016: 59-75.
|
[5] |
PARKIN D M,, CHEN V W,, FERLAY J, et al.Comparability and quality control in cancer registration. IARC technical report No 19[M]. Lyon:IARC Press, 1994.
|
[6] |
上海市疾病预防控制中心.上海市恶性肿瘤发病率、死亡率和生存率: 2001-2012[M].上海:上海科学普及出版社, 2017: 1-6.
|
|
Shanghai Municipal Center for Disease Control and Prevention.Incidence rate, mortality and survival rate of malignant tumors in Shanghai: 2001-2012[M]. Shanghai:Shanghai Science Popularization Press, 2017: 1-6.
|
[7] |
KURMAN R J,, CARCANGIU M L,, HERRINGTON C S, et al.WHO classification of tumours of female reproductive organs, 4th Ed, volume 6[M]. Lyon:IARC Press, 2014.
|
[8] |
卢伟,, 郑莹.肿瘤命名与编码[M]. 上海:第二军医大学出版社, 2011.
|
|
LU W,, ZHENG Y.Tumor nomenclature and coding[M]. Shanghai:the Second Military Medical University Press, 2011.
|
[9] |
SEGI M. Cancer mortality for selected sites in 24 countries (1950-1957)[M].Japan:Tohoku University School of Medicine, 1960.
|
[10] |
Statistical Research and Applications Branch,National Cancer Institute. Joinpoint regression program, Version 4.8.0.1[CP]. April, 2020.
|
[11] |
KIM H J,, FAY M P,, FEUER E J, et al.Permutation tests for joinpoint regression with applications to cancer rates[J]. Stat Med, 2000, 19(3): 335-351.
doi: 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z
|
[12] |
FERLAY J,, ERVIK M,,LAM F,et al. Global cancer observatory: cancer today[DB/OL]. Lyon, France:International Agency for Research on Cancer.https://gco.iarc.fr/today, accessed.
|
[13] |
《上海卫生志》编纂委员会.上海卫生志[M]. 上海:上海社会科学院出版社, 1998.
|
|
Compilation Committee of Shanghai Health Records.Shanghai Journal of Health[M]. Shanghai:Shanghai Academy of Social Sciences Press, 1998.
|
[14] |
HUANG Z Z,, ZHENG Y,, WEN W Q, et al.Incidence and mortality of gynaecological cancers: secular trends in urban Shanghai, China over 40 years[J]. Eur J Cancer, 2016, 63: 1-10.
doi: 10.1016/j.ejca.2016.04.016
|
[15] |
ZHANG S W,, SUN K X,, ZHENG R S, et al.Cancer incidence and mortality in China, 2015[J]. J Natl Cancer Cent, 2021, 1(1): 2-11.
|
[16] |
HENLEY S J,, WARD E M,, SCOTT S, et al.Annual report to the nation on the status of cancer, part Ⅰ: national cancer statistics[J]. Cancer, 2020, 126(10): 2225-2249.
doi: 10.1002/cncr.32802
|
[17] |
International Agency for Research on Cancer. Cervix cancer screening. IARC handbooks of cancer prevention.Volume 10[M]. Lyon:IARC Press, 2005.
|
[18] |
WALBOOMERS J M,, JACOBS M V,, MANOS M M, et al.Human papillomavirus is a necessary cause of invasive cervical cancer worldwide[J]. J Pathol, 1999, 189(1): 12-19.
doi: 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F
|
[19] |
BRAY F,, LOOS A H,, MCCARRON P, et al.Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening[J]. Cancer Epidemiol Biomarkers Prev, 2005, 14(3): 677-686.
doi: 10.1158/1055-9965.EPI-04-0569
|
[20] |
UTADA M,, CHERNYAVSKIY P,, LEE W J, et al.Increasing risk of uterine cervical cancer among young Japanese women: comparison of incidence trends in Japan, South Korea and Japanese-Americans between 1985 and 2012[J]. Int J Cancer, 2019, 144(9): 2144-2152.
doi: 10.1002/ijc.32014
|
[21] |
ZHAO F H,, LEWKOWITZ A K,, HU S Y, et al.Prevalence of human papillomavirus and cervical intraepithelial neoplasia in China: a pooled analysis of 17 population-based studies[J]. Int J Cancer, 2012, 131(12): 2929-2938.
doi: 10.1002/ijc.27571
|
[22] |
LI J,, HUANG R,, SCHMIDT J E, et al.Epidemiological features of human papillomavirus (HPV) infection among women living in Mainland China[J]. Asian Pac J Cancer Prev, 2013, 14(7): 4015-4023.
doi: 10.7314/APJCP.2013.14.7.4015
|
[23] |
李新建,,徐继英,卢伟主编. 上海市疾病预防控制中心编著.上海市慢性病及其危险因素监测报告-2007[M]. 上海:上海科学普及出版社, 2012.
|
|
LI J X,, XU J Y,LU W editor in chief. Edited by Shanghai Center for Disease Control and Prevention. Surveillance report on chronic diseases and their risk factors in Shanghai- 2007[M]. Shanghai:Shanghai Science Popularization Press, 2012.
|
24. |
李新建,,徐继英,,仲伟鉴主编. 上海市疾病预防控制中心编著.上海市慢性病及其危险因素监测报告-2010[M]. 上海:上海科学普及出版社, 2012.
|
|
LI J X,, XU J Y,,ZHONG W J editor in chief. Edited by Shanghai Center for Disease Control and Prevention. Surveillance report on chronic diseases and their risk factors in Shanghai- 2010[M]. Shanghai:Shanghai Science Popularization Press, 2012.
|
25. |
上海市疾病预防控制中心.上海市慢性病及其危险因素监测报告-2013[M]. 上海:上海科学普及出版社, 2014.
|
|
Shanghai Municipal Center for Disease Control and Prevention.Surveillance report on chronic diseases and their risk factors in Shanghai-2013[M]. Shanghai:Shanghai Science Popularization Press, 2014.
|
26. |
World Health Organization.WHO director-general calls for all countries to take action to help end the suffering caused by cervical cancer[EB/OL]. WHO, 2018. [2021-07-15]who.int/reproductivehealth/call-to-action-elimination-cervical-cancer/en/.
|
27. |
张韶凯,, 赵方辉,, 乔友林.中国宫颈癌防治研究20年历程与成就[J]. 中华流行病学杂志, 2020, 41(6): 809-812.
|
|
ZHANG S K,, ZHAO F H,, QIAO Y L.Development and achievements regarding the prevention and control of cervical cancer in the last 20 years in China[J]. Chin J Epidemiol, 2020, 41(6): 809-812.
|
28. |
FORCE U P S T,, CURRY S J,, KRIST A H, et al.Screening for cervical cancer: US preventive services task force recommendation statement[J]. JAMA, 2018, 320(7): 674-686.
doi: 10.1001/jama.2018.10897
|
29. |
黄留叶,, 赵雪莲,, 赵方辉.宫颈癌的发病与死亡变化趋势及其预防策略进展[J]. 肿瘤综合治疗电子杂志, 2021, 7(2): 21-25.
|
|
HUANG L Y,, ZHAO X L,, ZHAO F H.Trend of cervical cancer incidence, mortality, and progress of prevention strategies[J]. J Multidiscip Cancer Manag Electron Version, 2021, 7(2): 21-25.
|
[30] |
彭鹏,, 鲍萍萍,, 王春芳, 等.上海市女性居民宫颈癌筛查知识和行为现状调查[J]. 环境与职业医学, 2014, 31(5): 342-346.
|
|
PENG P,, BAO P P,, WANG C F, et al.Knowledge and behavior of female residents in Shanghai regarding cervical cancer screening[J]. J Environ Occup Med, 2014, 31(5): 342-346.
|
[31] |
任文辉,, 赵艳霞,, 马兰, 等.我国贫困地区宫颈癌筛查效果及影响因素研究[J]. 中国妇产科临床杂志, 2020, 21(4): 388-391.
|
|
REN W H,, ZHAO Y X,, MA L, et al.Influencing factors of the quality of cervical cancer screening in poverty-stricken counties in China[J]. Chin J Clin Obstet Gynecol, 2020, 21(4): 388-391.
|
[32] |
黄静,, 杨湘红,, 刘爱, 等.农村地区妇女“两癌筛查”项目实施中的问题与对策[J]. 中国全科医学, 2020, 23(13): 1680-1686.
doi: 10.12114/j.issn.1007-9572.2019.00.509
|
|
HUANG J,, YANG X H,, LIU A, et al.Problems and countermeasures in the implementation of national cervical and breast screening program for women in rural areas[J]. Chin Gen Pract, 2020, 23(13): 1680-1686.
|
[33] |
吴春晓,, 郑莹.《上海市肿瘤登记管理办法》解读[J]. 上海预防医学, 2017, 29(7): 523-524.
|
|
WU C X,, ZHENG Y.Interpretation of Shanghai tumor registration management measures[J]. Shanghai J Prev Med, 2017, 29(7): 523-524.
|